Janney Montgomery Scott LLC reduced its stake in Henry Schein, Inc. (NASDAQ:HSIC) by 52.9% during the third quarter, according to its most recent filing with the SEC. The fund owned 11,730 shares of the company’s stock after selling 13,152 shares during the quarter. Janney Montgomery Scott LLC’s holdings in Henry Schein were worth $745,000 at the end of the most recent quarter.
Several other large investors also recently modified their holdings of the stock. Vanguard Group Inc. boosted its holdings in shares of Henry Schein by 2.4% in the 2nd quarter. Vanguard Group Inc. now owns 16,865,641 shares of the company’s stock worth $1,178,909,000 after buying an additional 391,485 shares during the last quarter. Longview Partners Guernsey LTD lifted its holdings in Henry Schein by 15.8% during the second quarter. Longview Partners Guernsey LTD now owns 15,527,241 shares of the company’s stock valued at $1,085,354,000 after purchasing an additional 2,117,869 shares during the last quarter. Atlanta Capital Management Co. L L C lifted its holdings in Henry Schein by 0.5% during the second quarter. Atlanta Capital Management Co. L L C now owns 6,343,280 shares of the company’s stock valued at $443,395,000 after purchasing an additional 30,201 shares during the last quarter. JPMorgan Chase & Co. lifted its holdings in Henry Schein by 9.8% during the second quarter. JPMorgan Chase & Co. now owns 2,664,995 shares of the company’s stock valued at $184,285,000 after purchasing an additional 238,078 shares during the last quarter. Finally, Northern Trust Corp lifted its holdings in Henry Schein by 1.1% during the second quarter. Northern Trust Corp now owns 1,959,014 shares of the company’s stock valued at $136,934,000 after purchasing an additional 20,415 shares during the last quarter.
In other news, CFO Steven Paladino sold 21,370 shares of the stock in a transaction dated Thursday, November 7th. The shares were sold at an average price of $68.83, for a total value of $1,470,897.10. Following the sale, the chief financial officer now directly owns 144,863 shares of the company’s stock, valued at $9,970,920.29. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Vice Chairman James P. Breslawski sold 6,856 shares of the stock in a transaction dated Wednesday, November 6th. The stock was sold at an average price of $66.96, for a total transaction of $459,077.76. Following the completion of the sale, the insider now directly owns 242,190 shares in the company, valued at $16,217,042.40. The disclosure for this sale can be found here. Over the last three months, insiders sold 123,655 shares of company stock worth $8,373,585. Insiders own 1.06% of the company’s stock.
Several equities research analysts have commented on HSIC shares. Cleveland Research reaffirmed a “hold” rating on shares of Henry Schein in a report on Friday, November 1st. BidaskClub downgraded shares of Henry Schein from a “hold” rating to a “sell” rating in a report on Thursday, September 26th. Barrington Research reaffirmed a “buy” rating and set a $75.00 price objective on shares of Henry Schein in a report on Wednesday, November 6th. TheStreet raised shares of Henry Schein from a “c+” rating to a “b” rating in a report on Monday, October 14th. Finally, Zacks Investment Research downgraded shares of Henry Schein from a “hold” rating to a “sell” rating and set a $71.00 price objective on the stock. in a report on Wednesday, November 6th. Six investment analysts have rated the stock with a sell rating, seven have given a hold rating and four have given a buy rating to the company. Henry Schein has an average rating of “Hold” and an average target price of $72.17.
Shares of Henry Schein stock traded up $0.65 on Tuesday, reaching $68.05. The stock had a trading volume of 19,437 shares, compared to its average volume of 1,179,441. Henry Schein, Inc. has a 1 year low of $56.58 and a 1 year high of $72.81. The company has a market cap of $10.11 billion, a P/E ratio of 16.52, a price-to-earnings-growth ratio of 2.71 and a beta of 0.85. The company has a current ratio of 1.63, a quick ratio of 0.92 and a debt-to-equity ratio of 0.30. The business’s 50 day moving average is $63.41 and its two-hundred day moving average is $65.42.
Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings results on Tuesday, November 5th. The company reported $0.90 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.86 by $0.04. Henry Schein had a net margin of 4.66% and a return on equity of 15.93%. The firm had revenue of $2.51 billion for the quarter, compared to the consensus estimate of $2.52 billion. During the same period in the prior year, the firm posted $1.03 earnings per share. The company’s revenue for the quarter was up 6.5% on a year-over-year basis. On average, equities analysts anticipate that Henry Schein, Inc. will post 3.45 EPS for the current fiscal year.
Henry Schein announced that its Board of Directors has initiated a share repurchase program on Thursday, October 31st that permits the company to repurchase $400.00 million in outstanding shares. This repurchase authorization permits the company to purchase up to 4.3% of its shares through open market purchases. Shares repurchase programs are usually an indication that the company’s management believes its stock is undervalued.
Henry Schein Profile
Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Further Reading: What are high-yield dividend stocks?
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.